Edit 

WHAT WE DO

Edit

the Living for

the Better

WHAT WE DO

Akribion Genomics develops groundbreaking CRISPR nucleases into a new class of genetics-based cancer therapies and advanced genome editing tools.

Powered by BRAIN Biotech Group BioIncubator

LEARN MORE ABOUT OUR TECHNOLOGY

All of Akribion’s R&D efforts are based on a proprietary treasure box of more than 2,000 novel CRISPR nuclease sequences identified through a terabase-pair scale metagenomic screening.

Our Technology Advantage

Get an insight into our innovative technologies and learn more about our novel CRISPR nucleases. Discover the potential of our technology and find the right solution for you.

WHERE TO APPLY OUR TECHNOLOGY

We provide superior solutions for applications in health and biotech

Our genome editing technologies are a core enabler for many markets.

Genome Editing solutions for the megatrends

HOW TO ACCESS OUR TECHNOLOGY

EAGER TO INVEST?

Why invest in Akribion?

Are you interested to become part of our journey? Here are six reasons why you should invest in Akribion Genomics.

Reasons to invest in Akribion genomis

READ THE NEWS

MEET THE TEAM

A dynamic mix of highly experienced scientists and executives with a passion for genome editing.

That’s us

The Akribion team is a dynamic mix of highly experienced scientists and leaders with a passion for genome editing. We are constantly looking for great minds to join our team, so have a look at our job opportunities.

GET IN TOUCH

Ready to collaborate?
Get in touch!

* required field

Fill out this field
Fill out this field
Fill out this field
Please enter a valid email address.
Fill out this field
You need to agree with the terms to proceed